Libtayo is now approved for the first-line treatment of patients. Call our team at 972-548-9690 to see if this treatment is right for you.

New treatment options for resectable EGFRm Non-Small Cell Lung Cancer—Tagrisso: Convenient, once-daily dosing, taken at home.

A very rare and possibly one of the few case reports of acute promyelocytic leukemia (APL; acute myeloid leukemia M3, AML-M3) to be reported

Composite lymphoma is an extremely rare clinical entity.